Wockhardt Limited - Product Pipeline Review - 2014

Brochure
More information from http://www.researchandmarkets.com/reports/3020212/
Wockhardt Limited - Product Pipeline Review - 2014
Description:
Wockhardt Limited - Product Pipeline Review - 2014
Summary
This, ‘Wockhardt Limited - Product Pipeline Review - 2014’, provides an overview of the Wockhardt Limited’s
pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of
Wockhardt Limited’s, complete with comparative analysis at various stages, therapeutics assessment by
drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews
latest updates, and featured news and press releases, along with special features on late-stage and
discontinued projects.
This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000
indications. The report is built using data and information sourced from This proprietary databases,
Company/University websites, SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put together by This team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes
that ensures that all the profiles are updated with the latest set of information. Additionally, processes
including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain
competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in
-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of
data for the indicated disease.
Scope
- The report provides brief overview of Wockhardt Limited including business description, key information
and facts, and its locations and subsidiaries
- The report reviews current pipeline of Wockhardt Limited’s human therapeutic division and enlists all their
major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products
along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Wockhardt Limited’s pipeline products
Reasons to buy
- Evaluate Wockhardt Limited’s strategic position with total access to detailed information on its product
pipeline
- Assess the growth potential of Wockhardt Limited in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Wockhardt Limited’s R&D portfolio and develop
key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Wockhardt Limited and exploit
collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies
to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Wockhardt Limited
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the
most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Wockhardt Limited and identify potential opportunities
in those areas
- Avoid Intellectual Property Rights related issues
Contents:
List of Tables
List of Figures
Wockhardt Limited Snapshot
Wockhardt Limited Overview
Key Information
Key Facts
Wockhardt Limited - Research and Development Overview
Key Therapeutic Areas
Wockhardt Limited - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Wockhardt Limited - Pipeline Products Glance
Wockhardt Limited - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
Wockhardt Limited - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Wockhardt Limited - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Wockhardt Limited - Drug Profiles
varicella vaccine
Product Description
Mechanism of Action
R&D Progress
WCK-2349
Product Description
Mechanism of Action
R&D Progress
WCK-771
Product Description
Mechanism of Action
R&D Progress
tenatoprazole
Product Description
Mechanism of Action
R&D Progress
Second Generation Ketolides
Product Description
Mechanism of Action
R&D Progress
Second Generation Oxas
Product Description
Mechanism of Action
R&D Progress
WCK-4086
Product Description
Mechanism of Action
R&D Progress
WCK-4873
Product Description
Mechanism of Action
R&D Progress
WCK-4282
Product Description
Mechanism of Action
R&D Progress
WCK-5107/5222
Product Description
Mechanism of Action
R&D Progress
Wockhardt Limited - Pipeline Analysis
Wockhardt Limited - Pipeline Products by Target
Wockhardt Limited - Pipeline Products by Route of Administration
Wockhardt Limited - Pipeline Products by Molecule Type
Wockhardt Limited - Pipeline Products by Mechanism of Action
Wockhardt Limited - Recent Pipeline Updates
Wockhardt Limited - Dormant Projects
Wockhardt Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Wockhardt Limited, Key Information
Wockhardt Limited, Key Facts
Wockhardt Limited - Pipeline by Indication, 2014
Wockhardt Limited - Pipeline by Stage of Development, 2014
Wockhardt Limited - Monotherapy Products in Pipeline, 2014
Wockhardt Limited - Phase III, 2014
Wockhardt Limited - Phase II, 2014
Wockhardt Limited - Phase I, 2014
Wockhardt Limited - Preclinical, 2014
Wockhardt Limited - Discovery, 2014
Wockhardt Limited - Pipeline by Target, 2014
Wockhardt Limited - Pipeline by Route of Administration, 2014
Wockhardt Limited - Pipeline by Molecule Type, 2014
Wockhardt Limited - Pipeline Products by Mechanism of Action, 2014
Wockhardt Limited - Recent Pipeline Updates, 2014
Wockhardt Limited - Dormant Developmental Projects,2014
Wockhardt Limited, Other Locations
Wockhardt Limited, Subsidiaries
List of Figures
Wockhardt Limited - Pipeline by Top 10 Indication, 2014
Wockhardt Limited - Pipeline by Stage of Development, 2014
Wockhardt Limited - Monotherapy Products in Pipeline, 2014
Wockhardt Limited - Pipeline by Top 10 Target, 2014
Wockhardt Limited - Pipeline by Top 10 Route of Administration, 2014
Wockhardt Limited - Pipeline by Top 10 Molecule Type, 2014
Wockhardt Limited - Pipeline Products by Top 10 Mechanism of Action, 2014
Ordering:
Order Online - http://www.researchandmarkets.com/reports/3020212/
Order by Fax - using the form below
Order by Post - print the order form below and send to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from
USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit
http://www.researchandmarkets.com/contact/
Order Information
Please verify that the product information is correct and select the format(s) you require.
Product Name:
Wockhardt Limited - Product Pipeline Review - 2014
Web Address:
http://www.researchandmarkets.com/reports/3020212/
Office Code:
SCE7XA22
Product Formats
Please select the product formats and quantity you require:
Quantity
Electronic (PDF) Single User:
USD 1500
Electronic (PDF) Site License:
USD 3000
Electronic (PDF) Enterprisewide:
USD 4500
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title:
First Name:
Mr
Mrs
Dr
Miss
Last Name:
Email Address: *
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
* Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)
Ms
Prof
Page 2 of 2
Payment Information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by credit card:
You will receive an email with a link to a secure webpage to enter your
credit card details.
Pay by check:
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Center,
Taylors Lane,
Dublin 8,
Ireland.
Pay by wire transfer:
Please transfer funds to:
Account number
833 130 83
Sort code
98-53-30
Swift code
ULSBIE2D
IBAN number
IE78ULSB98533083313083
Bank Address
Ulster Bank,
27-35 Main Street,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at
http://www.researchandmarkets.com/info/terms.asp
Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353-1-481-1716 or +353-1-653-1571 - From Rest of World

Download Report